No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Panbela Therapeutics Reduces CEO and CFO Salaries
Panbela Therapeutics Implements Retention Bonuses for Executives
Panbela Therapeutics, Inc. (PBLA) Q3 2024 Earnings Call Transcript Summary
Panbela Therapeutics | 10-Q: Q3 2024 Earnings Report
Panbela Therapeutics Q3 EPS $(1.48) Up From $(53.74) YoY
Express News | Panbela Provides Business Update and Reports Q3 2024 Financial Results